Esophagogastric Junction Adenocarcinoma Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
Esophagogastric Junction Adenocarcinoma
Sun Yat-sen University37 enrolled1 locationNCT05170503
Recruiting
Phase 3
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd.354 enrolled1 locationNCT05978050